Related Experiment Videos
[Correction of hyperlipidemia with Allicor].
Klinicheskaia Meditsina
|May 29, 2004
Summary
Long-acting garlic powder tablets, Allicor, effectively lowered total and LDL cholesterol while raising HDL cholesterol in men with mild hypercholesterolemia. This suggests Allicor can help manage lipid levels in individuals with moderate hyperlipidemia.
Area of Science:
- Cardiovascular Health
- Nutritional Science
- Pharmacology
Background:
- Hypercholesterolemia is a significant risk factor for cardiovascular disease.
- Dietary interventions and supplements are explored for lipid management.
- Garlic has been traditionally recognized for its potential health benefits.
Purpose of the Study:
- To investigate the hypocholesterolemic effects of long-acting garlic powder tablets (Allicor).
- To evaluate Allicor's impact on lipid profiles in men with mild hypercholesterolemia.
Main Methods:
- A double-blind, placebo-controlled study design was employed.
- Participants were divided into two groups: one receiving Allicor (600 mg daily), the other a placebo.
- Lipid profiles, including total cholesterol, LDL, and HDL cholesterol, were monitored.
Main Results:
- Allicor significantly lowered total cholesterol levels.
- Allicor demonstrated a reduction in low-density lipoprotein (LDL) cholesterol.
- Allicor intake led to an increase in high-density lipoprotein (HDL) cholesterol.
Conclusions:
- Allicor exhibits significant hypocholesterolemic properties.
- The study supports the recommendation of Allicor for correcting lipid content in patients with moderate hyperlipidemia.
- Long-acting garlic supplementation shows promise in managing dyslipidemia.